Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ECTRIMS 2022 | Implementation of novel imaging biomarkers in clinical practice

Jaume Sastre-Garriga, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, discusses the appropriate use of MRI in routine clinical practice. As novel imaging biomarkers such as central vein sign and paramagnetic rim lesions are developed, it is necessary to plan their implementation in routine clinical practice to ensure all patients have access to new diagnostic approaches. Guidelines on MRI in multiple sclerosis from MAGNIMS, CMSC, and NAIMS have recently been updated, but there is a critical need for advocacy and dissemination, particularly at the local level, to improve compliance. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2022 in Amsterdam, The Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


J Sastre-Garriga has received grants and personal fees from Genzyme, personal fees from Almirall, Biogen, Celgene, Merck, Bayer, Biopass, Bial, Novartis, Roche and Teva, and he is European co-Editor of Multiple Sclerosis Journal and Scientific Director of Revista de Neurologia.